NCT06523569 Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
| NCT ID | NCT06523569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Hypertension in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-11-07 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-11-07 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
Eligibility Criteria
Inclusion Criteria: * Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital) * Live birth at any gestational age * Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension) Exclusion Criteria: * HELLP syndrome * History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease) * Current Omron remote patient monitoring or Noom user * BMI\<18.5 kg/m2 at enrollment * Inadequate gestational weight gain or gestational weight loss
Contact & Investigator
Priya M Freaney, MD
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT06523569 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 99 Years, studying Hypertension in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06523569 currently recruiting?
Yes, NCT06523569 is actively recruiting participants. Contact the research team at priya.freaney@northwestern.edu for enrollment information.
Where is the NCT06523569 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06523569 clinical trial?
NCT06523569 is sponsored by Northwestern University. The principal investigator is Priya M Freaney, MD at Northwestern University. The trial plans to enroll 120 participants.